View Press Releases
Genedata Highlights Combination Screening and Surface Plasmon Resonance at SLAS 2015
BASEL, SWITZERLAND - Feb 4, 2015 -
Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced its Combination Screening Colloquium at the 4th Annual Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition in Washington, DC (February 8). Genedata will also offer SLAS tutorials on combination screening and surface plasmon resonance (SPR) at the conference. Currently, the majority of leading global pharmaceutical companies use Genedata Screener® as their screening platform for the analysis and management of all plate-based screening data with applications in High Throughput Screening, High Content Screening, Label-free Screening, Ion Channel Screening and Cross-assay Profiling. Live demonstrations of the Genedata Screener platform will be conducted during SLAS 2015 at the Walter E. Washington Convention Center (February 7 - 11; Booth #1010).
Combination Screening Colloquium
Compound Combination Screening is rapidly gaining ground as a
new lead-finding technique for oncology, infectious diseases, and
drug repurposing. These experiments have made significant progress
in the areas of automation and throughput, enabled by technological
advances in nanoliter liquid handling and flexible plate
preparation, which fuel standardization and automation of data
analysis as well. Genedata Screener for Combination Screening
supports the analysis of high-throughput compound combination
experiments from raw data to obtain synergy scores and combination
indices. At the Genedata SLAS Combination Screening Colloquium,
some of the industry's most experienced combination screening
scientists from around the world together with Genedata
computational experts will discuss current methods and challenges
for analyzing combination screens. Using case studies, the
Colloquium will examine best analysis practices, and automation and
standardization options for quickly obtaining more comprehensive
and significant results from those experiments.
"Over the years, we have collaborated with leading researchers in
the field of combination screening," noted Dr. Othmar Pfannes, CEO
of Genedata. "And, we want to share our learnings to help a broader
group of researchers address and overcome the challenges commonly
experienced in compound combination screening. Our SLAS Combination
Screening Colloquium will give the scientific community a forum in
which they can exchange ideas, discuss best practices, and define
areas of improvement for data analysis. Such exchange with the
scientific community enables us to continually incorporate
best-practices and learnings from the forefront of screening
science into our software systems, which in turn helps researchers
to directly apply these learnings in their daily drug discovery
efforts."
Genedata Screener Tutorial Sessions
Used as a platform for all plate-based screening, Genedata Screener supports a wide range of related applications and technologies. Genedata Screener SLAS tutorial sessions will showcase some of these applications.
In addition to the Colloquium on February 8, the Genedata Screener for Combination Screening tutorial (Feb. 9) will focus on how data analysis workflows can be standardized for efficiency yet customized to provide additional or modified algorithmic approaches. The Genedata Screener for SPR session (Feb. 10) will demonstrate a vendor-agnostic, single data analysis solution for all SPR/biosensor experiments. Automating all data pre-processing, the solution offers data visualization and analysis optimization on-the-fly, which enables users to focus on result generation and interpretation. Tutorials will examine challenges associated with a heterogeneous data analysis landscape and show the benefits of a common data analysis infrastructure.
Editorial Notes
Genedata Colloquium - Combination Screening
February 8; 12:00pm - 3:30pm
Marriott Marquis Washington
Email: oliver.leven@genedata.com
SLAS Tutorials
February 9; 12:00pm - 2:45pm: "Genedata Screener for Combination Screening: Mastering the Latest Challenge in Pharma R&D"
February 10; 9:30am - 10:15am: "Genedata Screener for SPR - Increase Productivity and Result Quality"
About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US.
Media Contact
Jackie Thrasivoulos
Genedata Screener
Public Relations
Phone: +1 508 380 6408
jackie.thrasivoulos@genedata.com
Disclaimer
The statements in this press release that relate to future plans,
events, or performance are forward-looking statements that involve
risks and uncertainties, including risks associated with
uncertainties related to contract cancellations, developing risks,
competitive factors, uncertainties pertaining to customer orders,
demand for products and services, development of markets for the
Company's products and services. Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak
only as of the date hereof. The Company undertakes no obligation to
release publicly the result of any revisions to these
forward-looking statements that may be made to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events.
All product and service names mentioned are the trademarks of their
respective companies.